Literature DB >> 31937811

Morphofunctional analysis of the retina in patients with type 1 diabetes without complications after 30 years of disease.

Riccardo Sacconi1, Francesca Lamanna1, Enrico Borrelli1, Giacomo Mulinacci2, Marco Casaluci1, Francesco Gelormini1, Adriano Carnevali1, Lea Querques1, Gianpaolo Zerbini2, Francesco Bandello1, Giuseppe Querques3.   

Abstract

There is a lack of studies evaluating the sub-clinical retinal changes in patients with long-term type 1 diabetes mellitus (T1DM) and without history of systemic/ocular complications. The aim of this cross-sectional study was to investigate sub-clinical structural and/or vascular retinal changes in patients with long-term (≥30 years) T1DM and without systemic/ocular complications ("happy few" patients) using structural optical coherence tomography (OCT), OCT-angiography and microperimetry. Twelve eyes of 12 consecutive T1DM patients (mean age 52 ± 12 years, mean duration of disease 35 ± 3 years, mean HbA1c level 7.3 ± 2.8%), without micro/macrovascular complications associated with long-standing T1DM, and twelve healthy subjects were consecutively included. No statistically significant differences were disclosed comparing patients and controls for age, sex, best-corrected visual acuity, central macular thickness, and choroidal thickness. Using OCT-angiography, we did not find any significant difference in foveal avascular zone area, perfusion density, vessel length density, and tortuosity. Moreover, no significant differences were disclosed in retinal nerve fiber layer and ganglion cell complex thickness using structural OCT. No differences were disclosed in retinal sensitivity by microperimetry. New diagnostic tools are able to confirm the presence of a particular population of patients with type 1 diabetes who have been completely spared from diabetic retinal complications. The finding of these "happy few" patients could help us to better understand and target future treatments for diabetes.

Entities:  

Mesh:

Year:  2020        PMID: 31937811      PMCID: PMC6959306          DOI: 10.1038/s41598-019-57034-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  1 in total

1.  Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and Müller cells alterations.

Authors:  Stela Vujosevic; Edoardo Midena
Journal:  J Diabetes Res       Date:  2013-06-12       Impact factor: 4.011

  1 in total
  5 in total

1.  Foveal avascular zone analysis by optical coherence tomography angiography in patients with type 1 and 2 diabetes and without clinical signs of diabetic retinopathy.

Authors:  Giovanni William Oliverio; Ida Ceravolo; Ahsan Bhatti; Costantino John Trombetta
Journal:  Int Ophthalmol       Date:  2020-11-06       Impact factor: 2.031

2.  Evidence for Structural and Functional Damage of the Inner Retina in Diabetes With No Diabetic Retinopathy.

Authors:  Giovanni Montesano; Giovanni Ometto; Bethany E Higgins; Radha Das; Katie W Graham; Usha Chakravarthy; Bernadette McGuiness; Ian S Young; Frank Kee; David M Wright; David P Crabb; Ruth E Hogg
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-03-01       Impact factor: 4.799

Review 3.  Optical coherence tomography angiography in the management of diabetic retinopathy.

Authors:  Enrico Borrelli; Riccardo Sacconi; Giuseppe Querques; Francesco Bandello
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

4.  Early microvascular changes in patients with prediabetes evaluated by optical coherence tomography angiography.

Authors:  Juan D Arias; Francisco J Arango; Maria Margarita Parra; Ronald M Sánchez-Ávila; Gustavo A Parra-Serrano; Andrea T Hoyos; Silvia J Granados; Eduardo J Viteri; Ivetteh Gaibor-Santos; Yanny Perez
Journal:  Ther Adv Ophthalmol       Date:  2021-10-21

5.  Topical nerve growth factor prevents neurodegenerative and vascular stages of diabetic retinopathy.

Authors:  Gianpaolo Zerbini; Silvia Maestroni; Letizia Leocani; Andrea Mosca; Michela Godi; Renata Paleari; Arianna Belvedere; Daniela Gabellini; Paola Tirassa; Valerio Castoldi; Ilaria Viganò; Silvia Galbiati; Valentina Turco; Alessandro Lambiase; Paolo Rama
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.